Patents by Inventor Dennis Elias Saadeh

Dennis Elias Saadeh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230302032
    Abstract: Pharmaceutical compositions are described, the compositions comprising a therapeutically effective quantity of at least one glycopeptide antibiotic, at least one aminoglycoside antibiotic, and at least one amino acid. Methods for fabricating the compositions and using them are also described.
    Type: Application
    Filed: August 4, 2021
    Publication date: September 28, 2023
    Inventors: Dennis Elias Saadeh, Mark L. Baum
  • Patent number: 11766421
    Abstract: Pharmaceutical compositions are described, the compositions comprising therapeutically effective quantities of compounds (such as mycophenolic acid or cyclosporine) that are capable of treating, preventing, and/or or alleviating an ocular surface disease. Methods for fabricating the compositions and using them are also described.
    Type: Grant
    Filed: September 21, 2018
    Date of Patent: September 26, 2023
    Assignee: SURFACE OPHTHALMICS, INC.
    Inventors: Dennis Elias Saadeh, Kamran Hosseini
  • Patent number: 11534481
    Abstract: Pharmaceutical compositions for treating, mitigating or preventing autoimmune diseases and associated conditions are described herein. Methods for fabricating the compositions and using them are also described.
    Type: Grant
    Filed: January 28, 2020
    Date of Patent: December 27, 2022
    Assignee: Harrow IP, LLC
    Inventors: Dennis Elias Saadeh, Mark L. Baum
  • Publication number: 20220249510
    Abstract: Pharmaceutical compositions and methods for inducing conscious sedation using such compositions are described, the compositions including a benzodiazepine-based compound, an NMDA antagonist, and optionally a ?-blocker, antiemetic, an NSAID, and/or an antihistamine medication. Compositions may be incorporated into vehicles for extended release. Methods for fabricating the compositions and using them for anesthesiological applications are also described.
    Type: Application
    Filed: April 29, 2022
    Publication date: August 11, 2022
    Inventor: Dennis Elias Saadeh
  • Patent number: 11338018
    Abstract: Pharmaceutical compositions for treating, mitigating or preventing autoimmune diseases and associated conditions are described herein. Methods for fabricating the compositions and using them are also described.
    Type: Grant
    Filed: January 17, 2019
    Date of Patent: May 24, 2022
    Assignee: Harrow IP, LLC
    Inventors: Dennis Elias Saadeh, Mark L. Baum
  • Publication number: 20220143075
    Abstract: Pharmaceutical compositions including betamethasone sodium phosphate and mycophenolic acid and their use in the treatment of ocular surface disease.
    Type: Application
    Filed: January 24, 2022
    Publication date: May 12, 2022
    Inventors: Dennis Elias Saadeh, Kamran Hosseini
  • Publication number: 20220071945
    Abstract: Pharmaceutical compositions are described, the compositions comprising an immunosuppressant (such as mycophenolic acid) in combination with a very low concentration of a corticosteroid (such as betamethasone) that are capable of treating, preventing, and/or alleviating an ocular surface disease. Methods for fabricating the compositions and using them are also described.
    Type: Application
    Filed: December 4, 2019
    Publication date: March 10, 2022
    Inventors: Kamran Hosseini, Dennis Elias Saadeh, Richard L. Lindstrom
  • Patent number: 11266615
    Abstract: Pharmaceutical compositions that include aqueous suspensions of therapeutically effective quantity of a diaminopyrimidine compound (such as pyrimethamine) are provided herein. Methods for fabricating and using the compositions, and kits that include the compositions are also described.
    Type: Grant
    Filed: April 20, 2020
    Date of Patent: March 8, 2022
    Inventor: Dennis Elias Saadeh
  • Publication number: 20220031664
    Abstract: Pharmaceutical compositions and methods for inducing conscious sedation using such compositions are described, the compositions including antiemetic(s) and a-2-adrenergic receptor agonist(s), and optionally ?-blocker(s), NSAID(s), antihistamine(s), and/or pain reliever(s). The compositions may be incorporated into vehicles for extended release. Methods for fabricating the compositions and using them for anesthesiological applications are also described.
    Type: Application
    Filed: July 28, 2020
    Publication date: February 3, 2022
    Inventor: Dennis Elias Saadeh
  • Publication number: 20210085691
    Abstract: Pharmaceutical compositions and methods of use including a benzodiazepine-based compound, an NMDA antagonist, and optionally a ?-blocker, antiemetic, an NSAID, and/or an antihistamine medication.
    Type: Application
    Filed: December 9, 2020
    Publication date: March 25, 2021
    Inventor: Dennis Elias Saadeh
  • Publication number: 20210069237
    Abstract: Pharmaceutical compositions are described herein, among others, the compositions comprising anhydrous suspensions of a therapeutically effective quantity of a heparinoid, or a derivative or analog thereof, and to methods of preparing and using such compositions. The use of various heparinoids for these purposes is disclosed, such as pentosan, heparin, hyaluronic acid, chondroitin, and pharmaceutically acceptable salts thereof. Methods for fabricating the compositions and using them are also described.
    Type: Application
    Filed: September 1, 2020
    Publication date: March 11, 2021
    Inventor: Dennis Elias Saadeh
  • Publication number: 20210046001
    Abstract: Pharmaceutical ophthalmic compositions are described, the compositions consisting essentially of a therapeutically effective quantity of an anti-bacterial agent (such as moxifloxacin), a therapeutically effective quantity of an anti-inflammatory agent (such as prednisolone), a combination of at least two solubilizing and suspending agents (of which one is a non-ionic polyoxyethlene-polyoxypropylene block copolymer), and a carrier. Methods for fabricating the compositions and using them are also described.
    Type: Application
    Filed: October 29, 2020
    Publication date: February 18, 2021
    Inventors: Jeffrey T. LIEGNER, John Scott KAROLCHYK, Bernard COVALESKY, Richard DILZER, Kallan PETERS, Dennis Elias Saadeh
  • Publication number: 20200352938
    Abstract: Pharmaceutical compositions for treating presbyopia are described, the compositions comprising choline esterase inhibitor(s) and several other components such as ?-1-adrenergic antagonist(s), non-steroid anti-inflammatory drug(s), and/or adrenergic antagonist(s). Methods for fabricating the compositions and using the compositions are also described.
    Type: Application
    Filed: April 24, 2020
    Publication date: November 12, 2020
    Inventor: Dennis Elias Saadeh
  • Publication number: 20200297734
    Abstract: Pharmaceutical compositions and methods for inducing conscious sedation using such compositions are described, the compositions including a benzodiazepine-based compound, an NMDA antagonist, and optionally a ?-blocker, antiemetic, an NSAID, and/or an antihistamine medication. Compositions may be incorporated into vehicles for extended release. Methods for fabricating the compositions and using them for anesthesiological applications are also described.
    Type: Application
    Filed: June 11, 2020
    Publication date: September 24, 2020
    Inventor: Dennis Elias Saadeh
  • Publication number: 20200289455
    Abstract: Pharmaceutical compositions are described, the compositions comprising therapeutically effective quantities of compounds (such as mycophenolic acid or cyclosporine) that are capable of treating, preventing, and/or or alleviating an ocular surface disease. Methods for fabricating the compositions and using them are also described.
    Type: Application
    Filed: September 21, 2018
    Publication date: September 17, 2020
    Inventors: Dennis Elias Saadeh, Kamran Hosseini
  • Publication number: 20200246287
    Abstract: Pharmaceutical compositions that include aqueous suspensions of therapeutically effective quantity of a diaminopyrimidine compound (such as pyrimethamine) are provided herein. Methods for fabricating and using the compositions, and kits that include the compositions are also described.
    Type: Application
    Filed: April 20, 2020
    Publication date: August 6, 2020
    Inventor: Dennis Elias Saadeh
  • Patent number: 10660891
    Abstract: Pharmaceutical compositions that include aqueous suspensions of a therapeutically effective quantity of a diaminopyrimidine compound (such as pyrimethamine) are provided herein. Methods for fabricating the compositions and using them are also described.
    Type: Grant
    Filed: June 6, 2019
    Date of Patent: May 26, 2020
    Assignee: Harrow IP, LLC
    Inventors: Dennis Elias Saadeh, Annette Marleau, Thomas Ichim
  • Publication number: 20200155450
    Abstract: Pharmaceutical compositions are described, the compositions comprising a therapeutically effective quantity of an active component and a quantity of a sterile gel. Methods for fabricating the compositions and using them for ophthalmic or burn-treating applications are also described.
    Type: Application
    Filed: January 27, 2020
    Publication date: May 21, 2020
    Inventors: John Scott Karolchyk, Dennis Elias Saadeh
  • Publication number: 20200155651
    Abstract: Pharmaceutical compositions for treating, mitigating or preventing autoimmune diseases and associated conditions are described herein. Methods for fabricating the compositions and using them are also described.
    Type: Application
    Filed: January 28, 2020
    Publication date: May 21, 2020
    Inventors: Dennis Elias Saadeh, Mark L. Baum
  • Publication number: 20200155568
    Abstract: Pharmaceutical compositions and methods for inducing conscious sedation using such compositions are described, the compositions comprising a benzodiazepine-based compound, a NMDA antagonist, and optionally a ?-blocker, antiemetic, an NSAID, and/or an antihistamine medication. Methods for fabricating the compositions and using them for anesthesiological applications are also described.
    Type: Application
    Filed: January 23, 2020
    Publication date: May 21, 2020
    Inventors: John Berdahl, Dennis Elias Saadeh, Mark Baum